Press Releases

ELRIG Appoints Dr Kelly Gray and Dr Elaine Duncan to its Board

• Strengthens leadership team to support next phase of growth as organisation evolves to meet needs of global drug discovery community • Drs Gray and Duncan to lead scientific programmes and early career initiatives, respectively

PrecisionLife and Ovation identify first potential genetic biomarkers to quantitatively predict GLP-1 efficacy response

PrecisionLife and Ovation today announced the results of the first phase of their collaboration to develop drug-response biomarkers to quantitively predict the efficacy, safety and tolerability of glucagon-like peptide-1 receptor agonist (GLP-1) therapies, and the extension of their partnership.

Healthcare Access Performance Leader BlockIt Rebrands as Alluvium Healthcare

Inceptua Group Appoints Healthcare Industry Leader Kurt Hilzinger as Chairman of the Board

Inceptua Group announces the appointment of Kurt J. Hilzinger as Chairman of the Board.

ClearNote Health’s Enhanced Avantect® Pancreatic Cancer Test Delivers Industry-Leading Early Detection Performance

ClearNote Health announced an enhanced version of its Avantect Pancreatic Cancer Test that delivers a higher overall cancer detection sensitivity of 82.6% and specificity of 97.5%.

Ambience Healthcare Expands “Chart Awareness” Across Its Intelligence Platform

Innovate UK awards over £300k SMART grant to Exeter HealthTech Research Centre and Sanome to advance AI-enabled early detection of hospital-acquired infections

Certara Introduces CRF Creator Module in Pinnacle 21® Enterprise Plus for Faster Clinical Study Start-Up in Drug Development

New module streamlines standardized CRF (case report form) design and EDC build to help clinical teams start studies faster.

Valley Diagnostics signs licence agreements with Aberystwyth University to commercialise innovative diagnostic tests

Valley Diagnostics Ltd., a Welsh diagnostics company commercialising next-generation point-of-care lateral flow tests (LFTs), has signed several licencing agreements with its research partner and collaborator Aberystwyth University to bring to market innovative diagnostic tests that will revolutionise disease detection.

Visby Medical Collaborates with Watchmaker Genomics to Enhance Respiratory Pathogen Detection in the At-Home Setting

Firstsource + Prosper AI Partner to Bring AI-Driven Voice Workflows to RCM

BrightHeart Announces VolusonTM Solution Store Collaboration to Deliver Expert-Level AI Support Across the Full Prenatal Ultrasound Exam

The addition of BrightHeart's B-Right AI Platform to the Voluson Solution store is poised to improve early detection of congenital defects, reduce diagnostic uncertainty, and ultimately support better outcomes for clinicians, expectant parents and their babies.

Ambience Healthcare Partners with MultiCare Health System on Enterprise Rollout of AI Platform

BetterWay Launches GLP-1 Blood Testing Panel at Retail Locations in Austin and Temple

BetterWay blood testing by Babson Diagnostics will launch a GLP-1 test panel at more than 25 retail locations in Austin and Temple, including Sam’s Club and Peoples Rx pharmacies.

Astoriom Acquires Precision Stability Storage

• Acquisition strengthens Astoriom’s stability storage capabilities to meet increasing demand across North America • Offers reliable, compliant, and accessible solutions to advance scientific discovery and product development

START Appoints Dr. Navid Hafez as Director of Clinical Research at Its New Los Angeles Site

Dr. Hafez will lead the new early-phase research site at Los Angeles Cancer Network, one of the nation’s largest and most diverse community-based oncology practices.

4D Path Joins Phase II Clinical Trial to Advance Predictive Biomarkers in Bladder Cancer

4D Path, a company dedicated to personalizing cancer care through a novel, physics-inspired approach to predicting tumor response to therapy, today announced its participation as an exploratory biomarker collaborator in the Phase II DAD-IO clinical study (NCT04724018) led by Dana-Farber Cancer Institute and supported by Gilead Sciences, Inc. This high-profile study is evaluating a novel combination therapy for patients with locally advanced or metastatic urothelial carcinoma (mUC), including bladder cancer, and represents an important step forward in 4D Path’s mission to redefine precision oncology.

Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035

Baylor Genetics Supports Bipartisan House Bill to Broaden Medicaid Access to Genomic Sequencing for Children who Meet Medical Criteria

Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, announced its support for the Genomic Answers for Children’s Health Act. This legislation, introduced in the House of Representatives with bipartisan support, aims to improve access to genomic sequencing by clarifying that such testing is covered under Medicaid’s “Early and Periodic Screening, Diagnostic, and Treatment Services” for children meeting certain clinical criteria.

ELRIG Announces Drs Stephen Ward and Annarita Miccio as Keynote Speakers for Cell and Gene Therapy 2026

• Inaugural event takes place from 9–10 March at Hinxton Hall in Cambridge, UK • Programme spans neurological disorders, sensory diseases, rare conditions, and cancer immunotherapy